Gemtuzumab ozogamicin s Midostaurinem v intenzivní léčbě CD33/FLT3+ AML – aktualizovaná data.

Weinbergerová,  Barbora; Čerňan, M.; Szotkowski,  Tomáš; Semerád,  Lukáš; Kabut, T.; Navrátilová, J.; Podstavková, N.; Procházková,  Jiřina; Ježíšková,  Ivana; Klemešová,  Iveta; Folta, A.; Mayer,  Jiří

Gemtuzumab ozogamicin s Midostaurinem v intenzivní léčbě CD33/FLT3+ AML – aktualizovaná data.

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data
Authors	WEINBERGEROVÁ Barbora ČERŇAN M. SZOTKOWSKI Tomáš SEMERÁD Lukáš KABUT T. NAVRÁTILOVÁ J. PODSTAVKOVÁ N. PROCHÁZKOVÁ Jiřina JEŽÍŠKOVÁ Ivana KLEMEŠOVÁ Iveta FOLTA A. MAYER Jiří
Year of publication	2023
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	Gemtuzumab ozogamicin with Midostaurin in the intensive treatment of CD33/FLT3+ AML - updated data - conference abstract.
Related projects:	National institute for cancer research